Prescription medication · Amylin Analog
pramlintide
Also sold as Symlin. Symlin is used to help manage blood sugar levels in adults with type 1 or type 2 diabetes.
Data updated 2026-05-15
- 89
- FDA reports
- 13
- InteractionsSeveral interactions
- In shortage
- FDA status
What the data shows
pramlintide (Symlin) is a prescription Amylin Analog, with 89 FDA adverse-event reports on file, with 13 documented drug interactions.
Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.
pramlintide (Symlin) is a prescription Amylin Analog. Symlin is used to help manage blood sugar levels in adults with type 1 or type 2 diabetes.
Symlin is a drug that helps control blood sugar in people with type 1 or type 2 diabetes who also use insulin. It works with insulin to lower blood sugar levels after meals.
Verify with FDA → · CMS NADAC pricing →
Drug Shortage Alert
pramlintide is currently listed as to be discontinued by the FDA. Affected manufacturer: AstraZeneca AB.
View all drug shortages →What it does
Symlin is used to help manage blood sugar levels in adults with type 1 or type 2 diabetes.
Common side effects
Nausea, Vomiting, Loss of appetite
Key warnings
Symlin can cause very low blood sugar, especially if you have type 1 diabetes.
The sections below are summarized in plain English from pramlintide's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Symlin is similar to a natural hormone in your body. It slows down how quickly food leaves your stomach. It also helps to prevent your liver from releasing too much sugar after you eat, and reduces your appetite.
Side Effects (from patient reports)
Based on 89 FDA adverse event reports.
Most-reported reactions
Adverse reactions in FAERS for pramlintide, by number of reports
- High blood sugar
High blood sugar
15 reports
- Sudden kidney damage
Sudden kidney damage
11 reports
- Long-term kidney disease
Long-term kidney disease
11 reports
- Feeling sick to your stomach
Feeling sick to your stomach
9 reports
- Shortness of breath
Shortness of breath
8 reports
- Feeling tired
Feeling tired
8 reports
- High blood pressure
High blood pressure
7 reports
- Kidney failure
Kidney failure
7 reports
- Weight loss
Weight loss
7 reports
- Pain in the chest
Pain in the chest
6 reports
What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.
Serious Warnings
Symlin can cause very low blood sugar, especially if you have type 1 diabetes. This can happen within 3 hours after a Symlin shot. To avoid this, follow your doctor's instructions carefully and check your blood sugar often. Make sure you know the signs of low blood sugar.
Known Drug Interactions
Drugs That May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analog (e.g., octreotide), and sulfonamide antibiotics. • Drugs that may increase the risk of hypoglycemia: antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analog (e.g., octreotide), and...
Mechanism: Both of these medications are used to lower blood sugar, so taking them together increases the chance of your blood sugar falling to a dangerous level.
Drugs That May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogs (e.g., octreotide), and sulfonamide antibiotics Intervention: Dosage reductions and increased frequency of glucose monitoring may be required when XULTOPHY 100/3.6 is coadministered with these drugs.
Mechanism: Both drugs work to lower blood sugar, so taking them at the same time can cause your blood sugar to drop too low.
Table 6: Clinically Significant Drug Interactions with LEVEMIR Drugs That May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogs (e.g., octreotide), and sulfonamide antibiotics, GLP-1 receptor agonists, DPP-4 inhibitors, SGLT-2 inhibitors.
Mechanism: Both drugs lower blood sugar, so taking them together increases the chance of your blood sugar dropping to a dangerous level.
7 DRUG INTERACTIONS Table 6 includes clinically significant drug interactions with BASAGLAR Table 6: Clinically Significant Drug Interactions with BASAGLAR Drugs That May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogs (e.g., octreotide), and sulfonamide antibiotics. Drugs that may increase the risk of hypoglycemia: antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents,...
Mechanism: Both medications are used to lower blood sugar, so using them at the same time increases the risk of hypoglycemia.
7 DRUG INTERACTIONS Table 6: Clinically Significant Drug Interactions with APIDRA Drugs that May Increase the Risk of Hypoglycemia Drugs: Antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analog (e.g., octreotide), and sulfonamide antibiotics.
Mechanism: Pramlintide can increase the risk of low blood sugar when taken with insulin.
This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.
Common Questions
Can Symlin be mixed with insulin?
What should I do if I feel nauseous after taking Symlin?
Can I share my Symlin pen with others?
Does Symlin cause weight loss?
What if I take other medications?
What should my A1c be before starting Symlin?
Can I use Symlin if I have gastroparesis?
What are the symptoms of low blood sugar?
How often should I check my blood sugar?
Can children use Symlin?
What are the common side effects of pramlintide?
Does pramlintide interact with other medications?
What drug class is pramlintide?
What pregnancy or breastfeeding source fields are listed for pramlintide?
Is pramlintide currently in shortage?
Related Medications in Amylin Analog
Other drugs grouped near pramlintide - same-class peers and common alternatives.
acarbose
Precose
Acarbose is a medicine that helps lower blood sugar levels in people with type 2 diabetes.
Compare with pramlintide →
alogliptin
Nesina
Compare with pramlintide →
bromocriptine
Cycloset
Bromocriptine (Cycloset) is a medicine that acts like dopamine in your body.
Compare with pramlintide →
canagliflozin
Invokana
Invokana is a medicine used with diet and exercise to lower blood sugar in adults with type 2 diabetes.
Compare with pramlintide →
colesevelam
Welchol
Colesevelam is a medicine that helps lower bad cholesterol (LDL-C) and control blood sugar in adults.
Compare with pramlintide →
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on pramlintide
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for pramlintide
The FDA label for pramlintide (sold under brand names such as Symlin) classifies it as a prescription-only medication in the Amylin Analog class. Symlin is used to help manage blood sugar levels in adults with type 1 or type 2 diabetes. Official labeling lists 9 commonly reported side effects, including Nausea, Vomiting, Loss of appetite.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 89 voluntary reports. The database also lists 13 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated moderate severity. Acquisition-cost data is surveyed weekly by CMS and updated as manufacturers report changes.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Shortage status: FDA Drug Shortages Database.
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: December 18, 2019
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages